OPRELSUS
Live / Applied — Second extension granted (statement of use) (as of 08 Oct 2025)
What this means for you
Not registered yet, but its 26 Jul 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98103302
- Mark type
- Stylized text
- Filed
- 26 Jul 2023
- Published for opposition
- 17 Sept 2024
- Attorney of record
- Jeannine Rittenhouse
Goods and services
- Class 005 — Pharmaceuticals: veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment, diagnosis, prevention and control of infectious diseases in food producing animals and livestock; veterinary preparations for enhancing reproduction in livestock; immunorestorative biopharmaceuticals for the prevention and treatment of viral, infectious, and metabolic diseases in animals; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; animal feed additives for use as nutritional supplements; veterinary preparations or animal feed additives for use in decreasing gas emissions from animals, animal carcasses, or animal waste; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; veterinary hormone preparations and hormone preparations in the nature of biological implants for animals, namely, progesterone, estrogen and testosterone; veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat; veterinary preparations for companion animals, namely, to treat and prevent parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders; veterinary preparations for companion animals for nonsurgical sterilization, namely, hormones for the control and prevention of reproductive functions; veterinary preparations for treating and preventing fleas, ticks, lice, flies, and mosquitos on companion animals; veterinary preparations, namely, vaccines for companion animals including horses; veterinary preparations to control diseases and parasites in fish
Owner
- ELANCO US INC., Indianapolis, IN, US
- ELANCO US INC., Greenfield, IN, US
Prosecution history
- 09 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Oct 2025 — SOU EXTENSION 2 GRANTED
- 08 Oct 2025 — SOU EXTENSION 2 FILED
- 08 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Apr 2025 — SOU EXTENSION 1 GRANTED
- 24 Apr 2025 — SOU EXTENSION 1 FILED
- 24 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Sept 2024 — PUBLISHED FOR OPPOSITION
- 28 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE